The Work of Dr Raju Kanukula
When medicine alone is not enough, communities become the cure. Dr Raju Kanukula at the University of Sydney is helping build the evidence base that proves it and the world is paying attention.
Social prescribing — the practice of connecting people to non-clinical community activities, arts, nature, volunteering, and peer support to improve health and wellbeing is one of the most exciting shifts in modern healthcare. Rather than reaching only for a prescription pad, clinicians increasingly reach for community. At the heart of the global research movement making this possible is Dr Raju Kanukula, Research Fellow at the University of Sydney, whose rigorous evidence-based work is placing Australia firmly at the forefront of the field.
Dr Kanukula’s research brings the precision of evidence-based medicine systematic review, meta-analysis, and robust methods to a domain that has historically struggled to generate the kind of peer-reviewed, internationally comparable data that moves health policy. His work maps outcomes, evaluates what works across diverse settings, and helps health systems understand how social prescribing can be scaled sustainably.
A global evidence base, built from Sydney
Australia’s journey with social prescribing has been remarkable. From early pilots in Sydney for people living with mental illness, to landmark systematic reviews of outcomes across more than thirteen countries, Australian researchers have been quietly constructing a body of evidence that the rest of the world is now drawing on. Dr Kanukula’s contributions represent some of the most methodologically rigorous work in this space combining the tools of clinical epidemiology with the ambitions of community health.
His focus on evidence synthesis understanding not just whether social prescribing works, but for whom, in what context, and measured how is exactly the kind of scholarship that transforms a promising idea into a durable pillar of health policy. The University of Sydney’s position as a world-leading research institution gives that work global reach and credibility.
“The Global Social Prescribing Alliance is creating a sustainable health model, improving wellbeing while generating meaningful jobs at scale.”
Gareth Presch · CEO, Global Social Prescribing Alliance (GSPA)
Gareth Presch, CEO of the Global Social Prescribing Alliance (GSPA) and founder of the World Health Innovation Summit, has spent nearly 25 years working across healthcare systems on multiple continents. He understands better than most how rare it is for a single institution to become a genuine global anchor for a fast-moving field. The recognition he extends to Dr Kanukula and the University of Sydney reflects both the quality of the research and the moment the movement finds itself in.
The GSPA — launched in February 2021 with the support of the UK Secretary of State for Health and Social Care and now active across more than 30 countries was built on precisely the kind of vision that Dr Kanukula’s research supports: that health is shaped by social, economic, and environmental factors, and that communities, when properly resourced and connected, are powerful medicine. The Alliance has developed the Global Playbook for Social Prescribing, presented at the United Nations High-Level Political Forum, and worked alongside the World Health Organization to embed social prescribing into international health frameworks.
Research that resonates across borders
What makes Dr Kanukula’s contributions particularly valuable to the global community is their transferability. Social prescribing looks different in a rural Australian community than it does in a London borough or a Japanese suburb yet the underlying human needs and the mechanisms by which connection and purpose improve health are remarkably consistent. By studying outcomes across contexts and synthesising evidence from multiple countries, his work helps practitioners everywhere ask better questions and design better programmes.
The systematic review of social prescribing outcomes across thirteen countries a landmark piece of scholarship drew on a framework developed in the United Kingdom and expanded it with rigorous international standards. That kind of collaborative, cumulative science is what the GSPA and its partners are working to accelerate. Having an institution of the University of Sydney’s standing leading that work from the Asia-Pacific region matters enormously for the field’s global credibility.
SOCIAL PRESCRIBING: WHAT THE EVIDENCE SHOWS
- Significant improvements in quality of life and self-reported health status across multiple trials
- Reduced burden on primary care and emergency services when community referral pathways are in place
- Strong outcomes for people living with mental illness, loneliness, and long-term conditions
- Benefits demonstrated across Australia, the UK, Ireland, Japan, Canada, New Zealand, and beyond
- Link workers — the human connectors at the heart of social prescribing represent a meaningful new healthcare workforce
A movement built on community and volunteers
Research and policy matter enormously, but social prescribing ultimately lives in communities. It is activated by link workers, sustained by local organisations, and scaled through networks of people who believe that connection is medicine. That is why the WHIS volunteer chapter movement growing rapidly across Ireland, the UK, India, the USA, Italy, Portugal, Argentina, and beyond is such a vital complement to the academic work being done in institutions like the University of Sydney.
“Dr Kanukula’s leadership in research and publications from the University of Sydney is a tremendous asset to our global community. Scholars like him give our volunteer chapters the evidence they need to advocate locally and connect globally. This is exactly the kind of partnership between rigorous research and grassroots energy that will transform health systems. We warmly welcome his work into the GSPA family.”
Ushma Issar · Global Lead, Volunteer Engagement, WHIS
Ushma Issar, who leads volunteer engagement for WHIS and serves as the point of contact for the growing network of WHIS Volunteer Chapters worldwide, knows that the movement’s power comes from this integration of evidence and community action. When researchers like Dr Kanukula publish findings that demonstrate social prescribing’s impact, volunteer chapter leaders and link workers can walk into conversations with commissioners, funders, and policymakers holding credible, peer-reviewed evidence. The connection between the University of Sydney’s research output and the on-the-ground work of WHIS chapters is not incidental it is strategic.
What comes next
Social prescribing is at an inflection point. What began as a set of local experiments in community-based care has become a global movement with its own international alliance, a United Nations presence, and a fast-growing evidence base. The Global Social Prescribing Summit 2026 brings together policymakers, clinicians, academics, community organisations, and investors to chart the next phase of that journey one in which the Asia-Pacific region, led by researchers of Dr Kanukula’s calibre, will play an increasingly central role.
The University of Sydney’s commitment to evidence-based research in this field sends a clear signal: social prescribing is not a fringe idea. It is rigorous, it is scalable, and it is becoming essential infrastructure for health systems that want to address the social determinants of health the factors that clinical care alone can never reach.
Dr Raju Kanukula’s work is part of that infrastructure. And the global community from GSPA’s network of thirty-plus countries to the volunteer chapters building healthier communities from Dublin to Delhi is stronger for it.
Contact: raju.kanukula@sydney.edu.au
WELCOME TO THE GSPA TEAM
We are delighted to welcome Dr Raju Kanukula to the Global Social Prescribing Alliance as one of our Research and Academic Leads. His appointment reflects GSPA’s commitment to grounding our global work in the strongest possible evidence. If you are a researcher, academic, or practitioner with work related to social prescribing whether a systematic review, a pilot study, a policy evaluation, or a collaborative project in progress we warmly encourage you to reach out to Dr Kanukula directly. His expertise spans evidence synthesis, meta-analysis, and health research methods, and he is keen to connect with the global community. Together, we can build the evidence base that social prescribing deserves.